Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine eye drops for pediatric dry eye
ChiCTR2300077033Phase 4Recruiting
- Sponsor
- Wuhan Aier Eye Hospital
- Start
- Oct 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine in dry eye syndrome (DED) (2 arms), sponsored by Wuhan Aier Eye Hospital. Primary endpoints: Tear film breakup time (BUT) and Corneal fluorescein staining score. Started Oct 2023; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2300077033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077033.